Cormedix Inc (CRMD)
Cormedix stock today
Cormedix closed at $5.70 on October 30, 2026, down 25.46% on the day. Over the past year it returned -51.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $447 million.
| Period | CRMD | S&P 500 (SPY) |
|---|---|---|
| 1 month | -26.0% | -0.9% |
| 3 months | -24.0% | +2.1% |
| Year to date | -51.0% | +11.7% |
| 1 year | -51.0% | +12.4% |
| 3 years | +78.5% | +88.5% |
| 5 years | +17.2% | +76.0% |
Key statistics
- Market value
- $447M
- P/E (trailing)
- 2.6
- Forward P/E
- 20.6
- Price / sales
- 1.0
- 52-week range
- $5.70 to $12.73
- Next report
- Nov 16, 2026
About Cormedix
Cormedix develops antimicrobial treatments for medical devices and wounds.
Sector: Health Care
More on Cormedix
- Financials: revenue, earnings and segmentsRevenue +617% in the year to Dec 2025
- Valuation: P/E history and peersP/E 2.6
- Returns: what $1,000 became$1,000 ten years ago is $529.77 today
No forecast, no recommendation. This page describes Cormedix Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.